- Activity pressure is positive on the latest completed week.
6541
TAI
Week ended 07 Aug 2026
Weekly Investor Report
Tanvex BioPharma, Inc. · Healthcare · Biotechnology
Latest close
38.05 TWD
2.0%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -10.8% below the Trend Line and sits at 4.9% of its 52-week range. The latest completed week returned 2.0%, after a -6.7% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
21
out of 100
Latest Close
38.05 TWD
7 Aug 2026
1W Return
2.0%
latest completed week
4W Return
-6.7%
short-term follow-through
12W Return
-0.8%
quarterly tape
Trend Breadth
15.4%
8 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 40.75% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.0%
Latest completed week; four-week move -6.7%.
Indicator stack
8/49
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 40.75%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -10.8% below the Trend Line and sits at 4.9% of its 52-week range. The latest completed week returned 2.0%, after a -6.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0412-week average 0.02
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.04Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -6.7% over four weeks, -0.8% over 12 weeks, and -25.1% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.21Latest activity-pressure read.
Pressure change-62.9%Four-week change in activity pressure.
Leadership-44.10Latest relative-leadership reading.
RS change2.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-44.0%Distance below the 52-week high.
13-week volatility4.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+7.4%Week of 5 Jun.
Worst week-8.5%Week of 6 Mar.
Latest week+2.0%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains9
Flat weeks0
Modest losses9
Sharp losses6
Recent vol4.2%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank38 / 55
Group average-3.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD56.4%positive activity pressure
RS7.3%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank13 / 19
Group average-6.3%
Trend breadth31.6%
Trend31.6%active weekly trend signals
MD47.4%positive activity pressure
RS10.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape19/100
Trend, activity pressure, participation, and risk combine to a 19/100 tape read.
Indicator analysis23/100Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.
Activity pressure 0.04; No reversal markers Next-Week ExpectancyNegative 40.75%Next-week expectancy is negative with a 40.75% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 38.05 TWD | 2.0% | 42.67 TWD | 56.50 TWD | 0.21 | -44.10 | 1.4M | Off |
| 31 Jul 2026 | 37.30 TWD | -3.5% | 43.24 TWD | 56.70 TWD | 0.30 | -44.70 | 2.0M | Off |
| 24 Jul 2026 | 38.65 TWD | 0.7% | 43.93 TWD | 56.92 TWD | 0.46 | -44.28 | 1.8M | Off |
| 17 Jul 2026 | 38.40 TWD | -5.9% | 44.66 TWD | 57.12 TWD | 0.57 | -44.30 | 2.1M | Off |
| 10 Jul 2026 | 40.80 TWD | -1.4% | 45.36 TWD | 57.35 TWD | 0.57 | -45.35 | 1.6M | Off |
| 3 Jul 2026 | 41.40 TWD | 7.4% | 45.88 TWD | 57.57 TWD | 0.51 | -47.15 | 2.4M | Off |
| 26 Jun 2026 | 38.55 TWD | -4.7% | 46.32 TWD | 57.81 TWD | 0.46 | -49.19 | 5.3M | Off |
| 19 Jun 2026 | 40.45 TWD | 2.5% | 46.77 TWD | 58.04 TWD | 0.15 | -49.66 | 1.2M | Off |
| 12 Jun 2026 | 39.45 TWD | -5.8% | 47.27 TWD | 58.29 TWD | -0.24 | -49.19 | 2.0M | Off |
| 5 Jun 2026 | 41.90 TWD | 7.4% | 47.85 TWD | 58.55 TWD | -0.63 | -48.03 | 2.8M | Off |
| 29 May 2026 | 39.00 TWD | 1.0% | 48.33 TWD | 58.79 TWD | -1.18 | -52.08 | 2.1M | Off |
| 22 May 2026 | 38.60 TWD | 0.7% | 48.94 TWD | 59.07 TWD | -1.51 | -50.70 | 1.6M | Off |
| 15 May 2026 | 38.35 TWD | -2.4% | 49.70 TWD | 59.37 TWD | -1.62 | -50.53 | 3.1M | Off |
| 8 May 2026 | 39.30 TWD | -0.8% | 50.36 TWD | 59.62 TWD | -1.73 | -50.76 | 1.5M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.